There were no statistically significant differences between the reversion group (n = 16) and the persistent group (n = 58) in terms of sex, age, DM, IHD, and plasma IFN-γ protein level after T-cell mitogen stimulation and LTBI treatment. The gene discussed is IFNG; the disease is myocardial ischemia.